GlassScriptPhysician profile
Jacquin P Matthews
NPI 1073536017
$2,793.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,982 · 2020: $325 · 2021: $486.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $1,600.00 | 2019 | |
| Abbvie INC. | $376.09 | 2019-2021 | |
| Daiichi Sankyo INC. | $254.20 | 2019-2021 | |
| Minerva Surgical, INC | $124.74 | 2019 | |
| Evofem Biosciences, INC. | $99.91 | 2020-2021 | |
| Therapeuticsmd, INC. | $95.79 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $44.98 | 2019-2020 | |
| Avion Pharmaceuticals | $42.19 | 2020-2021 | |
| Intuitive Surgical, INC. | $33.20 | 2019 | |
| Exeltis, USA INC. | $18.46 | 2021 | |
| Agile Therapeutics, INC. | $17.97 | 2021 | |
| Pfizer INC. | $16.88 | 2021 | |
| Duchesnay USA Incorporated | $14.33 | 2019 | |
| Allergan, INC. | $14.00 | 2019 | |
| Levita Magnetics International Corp | $13.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $13.48 | 2019 | |
| Merck Sharp & Dohme LLC | $13.22 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquin Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.